MR弹性成像测量的肝脏硬度可预测治疗后早期肝细胞癌复发
本研究基于前瞻性收集的队列,分析192例符合米兰标准并接受肝切除、射频消融或经动脉化疗栓塞的肝细胞癌患者,发现MR弹性成像测量的肝脏硬度较高是早期复发的独立危险因素;肝硬度>5.5 kPa与较差的无复发生存期相关。
要点
- MR弹性成像测量的肝脏硬度较高是符合米兰标准肝细胞癌患者治疗后早期复发的独立预测因素。
- 肝硬度>5.5 kPa与更差的无复发生存期相关。
- 治疗前肝硬度高的患者可能从严格随访中获益。
核心结论
- MR弹性成像测量的肝脏硬度是符合米兰标准的肝细胞癌患者达到完全缓解后早期复发的独立预测因素。
研究设计与样本
- 前瞻性收集的队列(HCC-MRE队列)分析,纳入治疗前接受MR弹性成像检查、符合米兰标准且接受肝切除、射频消融或经动脉化疗栓塞的肝细胞癌患者,共192例。
- 患者接受肝切除96例、射频消融23例、经动脉化疗栓塞73例。
- 采用Cox回归和Kaplan-Meier分析评估肝脏硬度是否为早期复发的独立预测因素。
诊断标准与关键数值
- 肝脏硬度每升高1 kPa,早期肿瘤复发的风险比为1.12(95%CI 1.01-1.25,p=0.040)。
- 在肝切除/射频消融组中,肝脏硬度>4.5 kPa与早期复发风险升高相关(HR=2.95,95%CI 1.26-6.94,p=0.013)。
- 在经动脉化疗栓塞组中,肝脏硬度>6 kPa与早期复发风险升高相关(HR=2.94,95%CI 1.27-6.83,p=0.012)。
- 肝脏硬度>5.5 kPa与更差的无复发生存期相关。
临床应用与阅片要点
- 治疗前MR弹性成像测量的肝脏硬度可用于预测符合米兰标准的肝细胞癌患者治疗后早期复发风险。
- 肝脏硬度>5.5 kPa提示无复发生存期较差;肝切除/射频消融组中肝脏硬度>4.5 kPa、经动脉化疗栓塞组中肝脏硬度>6 kPa提示早期复发风险升高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Magnetic resonance elastography (MRE) is a non-invasive tool for measuring liver stiffness (LS) with high diagnostic accuracy. This study investigated whether quantified LS by MRE could predict early recurrence of patients with hepatocellular carcinoma (HCC) within the Milan criteria.
METHODS: A prospectively collected cohort, which included the HCC patients who underwent MRE before treatment (an HCC-MRE cohort), was analyzed. In the HCC-MRE cohort, only patients under the Milan criteria, who underwent hepatic resection, radiofrequency ablation (RFA), or transarterial chemoembolization (TACE), were reviewed. We investigated whether LS assessed by MRE was an independent predictor of early recurrence using Cox regressions and Kaplan-Meier analyses.
RESULTS: A total of 192 HCC patients under the Milan criteria who underwent hepatic resection (n = 96), RFA (n = 23), or TACE (n = 73) were included. Higher LS ratings (kPa; hazard ratio [HR] = 1.12; 95% confidence interval [CI] = 1.01-1.25; p = 0.040) emerged as an independent risk factor for early tumor recurrence. In the subgroup analysis, higher LS ratings were associated with higher risks of early HCC recurrence in both the resection/RFA group (> 4.5 kPa; HR = 2.95; 95% CI = 1.26-6.94; p = 0.013) and the TACE group (> 6 kPa; HR = 2.94; 95% CI = 1.27-6.83; p = 0.012).
CONCLUSION: LS assessed by MRE was an independent predictor of early recurrence among HCC patients under the Milan criteria after achieving a complete response.
KEY POINTS: • Liver parenchymal stiffness measured by MRE predicts early recurrence of treated HCC under Milan criteria. • A liver stiffness > 5.5 kPa was associated with worse recurrence-free survival. • Patients with high pre-treatment LS may benefit from stringent follow-up.
引用
- Cho HJ, Kim B, Kim HJ, et al. Liver stiffness measured by MR elastography is a predictor of early HCC recurrence after treatment. Eur Radiol. 2020. PMID: 32189053. doi:10.1007/s00330-020-06792-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。